Drug recall · September 11, 2024
Heparin recall
Why: Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Single Dose Container, Rx Only, Baxter USA, NDC 0338-0433-04
- Lots / codes
Lot # N008235, Exp 8/31/2024
- Quantity
- 44,208 containers
- Company
- Baxter Healthcare Corporation, Round Lake, IL
- Distribution
- Nationwide in the USA
- Initiated
- August 1, 2024 · Voluntary: Firm initiated
- Classified
- August 30, 2024
- Reported
- September 11, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Heparin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.